These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27853903)

  • 1. Does any drug to treat cancer target mTOR and iron hemostasis in neurodegenerative disorders?
    Jodeiri Farshbaf M; Ghaedi K
    Biometals; 2017 Feb; 30(1):1-16. PubMed ID: 27853903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Therapeutic Target for Inhibition of Neurodegeneration: Autophagy].
    Pupyshev AB; Korolenko TA; Tikhonova MA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2016 Sep; 66(5):515-540. PubMed ID: 30695399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis Mechanisms Involved in Neurodegenerative Diseases.
    Reichert CO; de Freitas FA; Sampaio-Silva J; Rokita-Rosa L; Barros PL; Levy D; Bydlowski SP
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others.
    Fernández-Ruiz J; Romero J; Ramos JA
    Handb Exp Pharmacol; 2015; 231():233-59. PubMed ID: 26408163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Function of Autophagy in Neurodegenerative Diseases.
    Kiriyama Y; Nochi H
    Int J Mol Sci; 2015 Nov; 16(11):26797-812. PubMed ID: 26569220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transition metals copper and iron in neurodegenerative diseases.
    Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
    Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review.
    Manoharan S; Guillemin GJ; Abiramasundari RS; Essa MM; Akbar M; Akbar MD
    Oxid Med Cell Longev; 2016; 2016():8590578. PubMed ID: 28116038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological metals and metal-targeting compounds in major neurodegenerative diseases.
    Barnham KJ; Bush AI
    Chem Soc Rev; 2014 Oct; 43(19):6727-49. PubMed ID: 25099276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
    Belaidi AA; Bush AI
    J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
    Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration.
    Masaldan S; Bush AI; Devos D; Rolland AS; Moreau C
    Free Radic Biol Med; 2019 Mar; 133():221-233. PubMed ID: 30266679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of connexins in neurodegenerative diseases (Review).
    Xing J; Xu C
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders.
    Mattson MP
    Ann N Y Acad Sci; 2004 Mar; 1012():37-50. PubMed ID: 15105254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
    Beal MF
    Ann Neurol; 1992 Feb; 31(2):119-30. PubMed ID: 1349466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological role of apoptosis signal-regulating kinase 1 in human diseases and its potential as a therapeutic target for cognitive disorders.
    Cheon SY; Cho KJ
    J Mol Med (Berl); 2019 Feb; 97(2):153-161. PubMed ID: 30617854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal.
    Romano A; Serviddio G; Calcagnini S; Villani R; Giudetti AM; Cassano T; Gaetani S
    Free Radic Biol Med; 2017 Oct; 111():281-293. PubMed ID: 28063940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer's and Parkinson's diseases.
    Singh YP; Pandey A; Vishwakarma S; Modi G
    Mol Divers; 2019 May; 23(2):509-526. PubMed ID: 30293116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurodegeneration: aging and dementia. Etiopathogenic role of electron transport disorders. Therapeutic possibilities].
    Klivényi P; Vécsei L
    Orv Hetil; 1997 Feb; 138(6):331-5. PubMed ID: 9082290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development.
    Ehrnhoefer DE; Wong BK; Hayden MR
    Nat Rev Drug Discov; 2011 Oct; 10(11):853-67. PubMed ID: 22015920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.